| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Biome Grow Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0045 |
| 52 Week High | CA$0.011 |
| 52 Week Low | CA$0.0012 |
| Beta | -0.13 |
| 1 Month Change | -50.00% |
| 3 Month Change | -23.73% |
| 1 Year Change | -40.79% |
| 3 Year Change | -93.80% |
| 5 Year Change | -98.88% |
| Change since IPO | -99.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| BIOI.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -33.3% | -1.5% | -3.2% |
| 1Y | -40.8% | 9.7% | 19.3% |
Return vs Industry: BIOI.F underperformed the US Pharmaceuticals industry which returned 9.7% over the past year.
Return vs Market: BIOI.F underperformed the US Market which returned 19.3% over the past year.
Price Volatility
| BIOI.F volatility | |
|---|---|
| BIOI.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BIOI.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine BIOI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Khurram Malik | www.biomegrow.com |
Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.
Biome Grow Inc. Fundamentals Summary
| BIOI.F fundamental statistics | |
|---|---|
| Market cap | US$410.98k |
| Earnings (TTM) | -US$1.56m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.3x
P/E RatioIs BIOI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BIOI.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.13m |
| Earnings | -CA$2.13m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.019 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -86.7% |
How did BIOI.F perform over the long term?
See historical performance and comparison